Economic Evaluation of Posaconazole Versus Fluconazole or Itraconazole in the Prevention of Invasive Fungal Infection in High-Risk Neutropenic Patients in Sweden

被引：0
|
作者：
Johan Lundberg
Martin Höglund
Magnus Björkholm
Örjan Åkerborg
机构：
[1] MSD Sweden (AB),Outcomes Research
[2] University Hospital,Division of Hematology, Department of Medical Science
[3] Karolinska University Hospital Solna,Department of Medicine
[4] Optum Insight,undefined
来源：
Clinical Drug Investigation | 2014年 / 34卷
关键词：
Acute Myeloid Leukemia; Fluconazole; Itraconazole; Invasive Aspergillosis; Acute Myeloid Leukemia Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：483 / 489
页数：6
相关论文
共 50 条
  • [21] Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands
    Stam, Wiro B.
    O'Sullivan, Amy K.
    Rijnders, Bart
    Lugtenburg, Elly
    Span, Lambert F. R.
    Janssen, Jeroen J. W. M.
    Jansen, Jeroen P.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 81 (06) : 467 - 474
  • [22] Cost-effectiveness of posaconazole versus fluconazole for prevention of invasive fungal infections in U.S. patients with graft-versus-host disease
    O'Sullivan, Amy K.
    Weinstein, Milton C.
    Pandya, Ankur
    Thompson, David
    Langston, Amelia A.
    Perfect, John R.
    Papadopoulos, George
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (02) : 149 - 156
  • [23] Prevention of invasive aspergillosis in high-risk patients: Universal versus preemptive, targeted treatment
    John W. Baddley
    Senu Apewokin
    Current Fungal Infection Reports, 2008, 2 (2) : 61 - 68
  • [24] Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison
    Tormo, Mar
    Perez-Martinez, Ariadna
    Calabuig, Marisa
    Carlos Hernandez-Boluda, Juan
    Amat, Paula
    Navarro, David
    Solano, Carlos
    MYCOSES, 2018, 61 (03) : 206 - 212
  • [25] Cost-Effectiveness of Posaconazole Compared with Standard Azole Therapy for Prevention of Invasive Fungal Infections in Patients at High Risk in Switzerland
    Greiner, Roger-Axel
    Meier, Yvonne
    Papadopoulos, George
    O'Sullivan, Amy K.
    Imhof, Alexander
    ONCOLOGY, 2010, 78 (3-4) : 172 - 180
  • [26] Cost-Effectiveness of Posaconazole vs. First-Generation Triazoles for the Prevention of Invasive Fungal Infections Among High-Risk Patients With Hematological Malignancies in China
    Shi, Changcheng
    Ye, Jian
    Xie, Yaping
    Dong, Rong
    Jin, Weizhong
    Wang, Linling
    Fang, Yingying
    Shan, Qiyuan
    Lin, Nengming
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [27] Randomized Trial of Micafungin for the Prevention of Invasive Fungal Infection in High-Risk Liver Transplant Recipients
    Saliba, Faouzi
    Pascher, Andreas
    Cointault, Olivier
    Laterre, Pierre-Francois
    Cervera, Carlos
    De Waele, Jan J.
    Cillo, Umberto
    Langer, Robert M.
    Lugano, Manuela
    Goeran-Ericzon, Bo
    Phillips, Stephen
    Tweddle, Lorraine
    Karas, Andreas
    Brown, Malcolm
    Fischer, Lutz
    CLINICAL INFECTIOUS DISEASES, 2015, 60 (07) : 997 - 1006
  • [28] Prevention and diagnosis of invasive fungal disease in high-risk patients within an integrative care pathway
    Barnes, Rosemary A.
    Stocking, Kate
    Bowden, Sarah
    Poynton, Matthew H.
    White, P. Lewis
    JOURNAL OF INFECTION, 2013, 67 (03) : 206 - 214
  • [29] Economic evaluation of posaconazole versus standard azole therapy as prophylaxis against invasive fungal infections in patients with prolonged neutropenia in Canada
    Monfared, Amir A. Tahami
    O'Sullivan, Amy K.
    Rotstein, Coleman
    Papadopoulos, George
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2012, 23 (02) : 59 - 64
  • [30] Pharmacokinetics and Safety of Posaconazole Tablet Formulation in Chinese Participants at High Risk for Invasive Fungal Infection
    Liu, Kaiyan
    Wu, Depei
    Li, Junmin
    Chen, Hu
    Ning, Hongmei
    Zhao, Ting
    Dai, Haiping
    Chen, Li
    Mangin, Eric
    Winchell, Gregory A.
    Waskin, Hetty
    Jiang, Jun
    Qiu, Yanping
    Zhao, Xu Min
    ADVANCES IN THERAPY, 2020, 37 (05) : 2493 - 2506
12345